VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Valneva SE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 17, 2026
$5.51−0.10 (-1.78%)
Close on Oct 19, 2026
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
€184.06M
€18.43M due within a year
Net debt
€62.53M
After €121.53M of cash
Implied interest rate
22.86%
FY2025 interest ÷ average debt
Interest coverage
-2.0×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, EUR
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Valneva's annual report. Trading prices and yields need FINRA TRACE data.